256 results on '"Delyon, Julie"'
Search Results
2. PD-1 blockade with pembrolizumab in classic or endemic Kaposi's sarcoma: a multicentre, single-arm, phase 2 study
3. Clinicopathologic and molecular characterization of melanomas mutated for CTNNB1 and MAPK
4. A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans
5. Severe immune-related hepatitis induced by immune checkpoint inhibitors: Clinical features and management proposal
6. Deep cutaneous fungal infections in solid-organ transplant recipients
7. Intermittent Versus Continuous Dosing of MAPK Inhibitors in the Treatment of BRAF-Mutated Melanoma
8. A Melanoma-Tailored Next-Generation Sequencing Panel Coupled with a Comprehensive Analysis to Improve Routine Melanoma Genotyping
9. Management of Kaposi sarcoma after solid organ transplantation: A European retrospective study
10. Avancées thérapeutiques récentes dans la prise en charge du carcinome à cellules de Merkel
11. Letter to the Editor re: Observational study investigating the level of support from a convolutional neural network in face and scalp lesions deemed diagnostically ‘unclear’ by dermatologists
12. Adjuvant or neoadjuvant treatment with immune checkpoint inhibitors: re-assessing the risk–benefit ratio
13. STAT3 Mediates Nilotinib Response in KIT-Altered Melanoma: A Phase II Multicenter Trial of the French Skin Cancer Network
14. Adjuvant or neoadjuvant treatment with immune checkpoint inhibitors: re-assessing the risk–benefit ratio
15. Targeted therapies in melanoma beyond BRAF: targeting NRAS-mutated and KIT-mutated melanoma
16. TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro
17. Kaposi sarcoma in HIV-positive solid organ transplant recipients: A French multicentric national study and literature review
18. Severe gastrointestinal toxicity of MEK inhibitors
19. Checkpoint inhibitor treatment induces an increase in HbA1c in nondiabetic patients
20. Refractory hypotension with fever revealing checkpoint inhibitor-induced hypophysitis
21. Supplementary Tables from Phase I–II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAFV600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism
22. Endemic Kaposi’s Sarcoma
23. Low-dose methotrexate-induced skin toxicity: Keratinocyte dystrophy as a histologic marker
24. The Ipilimumab Lesson in Melanoma: Achieving Long-Term Survival
25. A differential process mining analysis of COVID-19 management for cancer patients
26. Enteritis without colitis in patients treated with immune checkpoint inhibitors: a tricky diagnosis
27. Eruptive squamous cell carcinomas following an acute skin inflammatory disease: A series of four cases
28. Managing immune checkpoint inhibition in transplant recipients
29. Transient pituitary ACTH-dependent Cushing syndrome caused by an immune checkpoint inhibitor combination
30. Survival After Fulminant Myocarditis Induced by Immune-Checkpoint Inhibitors
31. 18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint Inhibitors
32. Sonidegib in the Treatment of Locally Advanced Basal Cell Carcinoma: A Retrospective Study
33. IL-6 blockade in cancer patients treated with immune checkpoint blockade: A win-win strategy
34. Yield of FDG PET/CT for Defining the Extent of Disease in Patients with Kaposi Sarcoma
35. Traitement par sonidégib des carcinomes basocellulaires localement avancés : étude rétrospective monocentrique
36. Développement d’un algorithme d’intelligence artificielle pour le diagnostic de mélanome à partir d’une banque d’images issues de la pratique courante
37. Carcinomes épidermoïdes éruptifs dans un contexte de dermatose inflammatoire aiguë : une série de 4 cas
38. EMMPRIN regulates β1 integrin-mediated adhesion through Kindlin-3 in human melanoma cells
39. Specific lymph node involvement in scleromyxedema: a new diagnostic entity for hypermetabolic lymphadenopathy
40. Outcome of pretransplant melanoma after solid organ transplantation: an observational study
41. Une complication digestive rare sous anti-PD-1 (pembrolizumab)
42. Systemic Treatment Initiation in Classical and Endemic Kaposi’s Sarcoma: Risk Factors and Global Multi-State Modelling in a Monocentric Cohort Study
43. Clinicopathologic and molecular characterization of melanomas mutated for CTNNB1 and MAPK
44. Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans
45. Phase I–II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAFV600MUT Metastatic Melanoma Patients: Uncovering CHEK2 as a Major Response Mechanism
46. Fgf2 induces resistance to nilotinib through mapk pathway activation in kit mutated melanoma
47. Treatment strategies and safety of rechallenge in the setting of immune checkpoint inhibitors-related myositis: a national multicentre study
48. More on Hemophilia A Induced by Ipilimumab
49. Cochleovestibular toxicity induced by immune checkpoint inhibition: a case series
50. Hemophilia A Induced by Ipilimumab
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.